Key Events This Week
24 Aug: Stock rises 1.36% amid weak Sensex
25 Aug: Price dips 0.96% despite Sensex gains
26 Aug: New 52-week and all-time highs reached (Rs.904.95 and Rs.898.90)
27 Aug: Further 52-week and all-time highs at Rs.939.3 and Rs.936
28 Aug: Week closes at Rs.900.60, down 2.54% on final day
24 August 2026: Positive Start Despite Market Weakness
Anthem Biosciences Ltd opened the week on a positive note, closing at Rs.883.35, up 1.36% from the previous close. This gain was notable as the Sensex declined by 0.12% to 36,770.21. The stock’s volume of 90,086 shares indicated healthy trading interest. The outperformance on a day when the broader market was weak suggested early investor confidence in the company’s prospects.
25 August 2026: Profit Taking Amid Broader Market Strength
The stock retreated 0.96% to Rs.874.90 on 25 August, despite the Sensex gaining 0.36% to 36,901.03. The volume dropped significantly to 28,058 shares, indicating reduced participation. This dip appeared to be a short-term correction following the previous day’s gains, as investors took profits amid a broadly positive market environment.
26 August 2026: Breakout to New Highs on Strong Volume
On 26 August, Anthem Biosciences Ltd surged 5.55% to close at Rs.923.45, hitting a new 52-week high of Rs.904.95 and an intraday peak of Rs.922. This marked a significant milestone, with the stock outperforming the Sensex, which declined marginally by 0.03% to 36,890.31. The volume spiked to 242,032 shares, reflecting strong market participation and conviction. Technical indicators were overwhelmingly bullish, with the stock trading above all key moving averages and supported by positive MACD and Bollinger Bands signals. Delivery volumes also increased sharply, underscoring robust investor interest.
Strong fundamentals, steady climb upward! This Large Cap from Telecommunication sector earned its Reliable Performer badge through consistent execution. Safety meets solid returns here!
- - Reliable Performer certified
- - Consistent execution proven
- - Large Cap safety pick
27 August 2026: Continued Momentum with New All-Time Highs
The bullish momentum extended into 27 August, with Anthem Biosciences Ltd reaching a new 52-week high of Rs.939.3 and an all-time high of Rs.936. The stock closed at Rs.924.05, up 0.06% on the day, despite the Sensex falling 0.52% to 36,700.18. The stock’s day change was a modest +0.60, but the cumulative gains over the last two sessions amounted to over 7%. Technical indicators remained supportive, with MACD, Bollinger Bands, KST, and Dow Theory all signalling bullish trends. The broader market showed signs of weakness, but the stock’s relative strength highlighted its resilience. Volume was healthy at 99,114 shares, and delivery volumes continued to rise, reflecting sustained investor interest.
28 August 2026: Profit Booking Weighs on Final Day
On the final trading day of the week, 28 August, the stock corrected 2.54% to close at Rs.900.60 on lower volume of 33,759 shares. This decline contrasted with a modest Sensex gain of 0.26% to 36,794.04. The pullback appeared to be profit booking after the strong rally earlier in the week. Despite the dip, the stock ended the week with a solid 3.34% gain, comfortably outperforming the Sensex’s marginal decline of 0.05%.
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-08-24 | Rs.883.35 | +1.36% | 36,770.21 | -0.12% |
| 2026-08-25 | Rs.874.90 | -0.96% | 36,901.03 | +0.36% |
| 2026-08-26 | Rs.923.45 | +5.55% | 36,890.31 | -0.03% |
| 2026-08-27 | Rs.924.05 | +0.06% | 36,700.18 | -0.52% |
| 2026-08-28 | Rs.900.60 | -2.54% | 36,794.04 | +0.26% |
Key Takeaways from the Week
Strong Price Momentum: Anthem Biosciences Ltd demonstrated robust price gains, hitting new 52-week and all-time highs on consecutive days (26 and 27 August), reflecting sustained bullish sentiment.
Outperformance vs Sensex: The stock’s 3.34% weekly gain contrasted with a flat Sensex, highlighting its relative strength amid mixed market conditions.
Technical Indicators Bullish: The stock traded above all major moving averages with positive MACD, Bollinger Bands, and Dow Theory signals, supporting the upward trend.
Volume and Delivery Trends: Significant spikes in volume and delivery percentages on key days indicated strong investor participation and conviction.
Short-Term Earnings Softness: Despite strong price action, recent quarterly results showed declines in net sales and profit after tax, suggesting caution on near-term fundamentals.
Holding Anthem Biosciences Ltd from ? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Conclusion: A Week of Milestones and Mixed Signals
Anthem Biosciences Ltd’s performance over the week ending 28 August 2026 was marked by significant milestones, including new 52-week and all-time highs that underscored strong investor enthusiasm and technical strength. The stock’s ability to outperform the Sensex amid a mixed market backdrop highlights its resilience and appeal within the Pharmaceuticals & Biotechnology sector.
However, the recent quarterly softness in earnings and the modest pullback on the final trading day suggest that investors should remain attentive to near-term fundamental developments. The current Mojo Score of 64.0 and Hold rating reflect a balanced view, acknowledging both the stock’s strong price momentum and the need for caution given valuation and earnings trends.
Overall, Anthem Biosciences Ltd remains a notable mid-cap performer with solid long-term growth metrics and a robust technical profile, making it a key stock to watch in the coming weeks.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
